Plate Market Review:
This week (1.10 ~ 1.14), Shenwan beauty care sector increased by + 0.03%. Shanghai Composite Index and gem index were – 1.63% and + 0.73% respectively. Shenwan beauty care sector outperformed Shanghai Composite Index by 1.66 PCT and underperformed gem index by 0.70 PCT.
Wind medical beauty and cosmetics index: this week, the CSI 300 index was – 1.98%, and the wind medical beauty index was + 0.98%, outperforming the CSI 300 market by 2.96pct; The wind cosmetics index was – 0.95%, outperforming the CSI 300 market by 1.03pct.
Industry highlights:
The State Food and Drug Administration issued the 18th issue of the quick overview of drug administration policies, emphasizing the main responsibilities of the entrusting party, i.e. the registrant and recorder of cosmetics, in the norms for the quality management of cosmetics production. The responsibilities of the entrusting party are as follows: 1. Establish a quality management system, determine the selection criteria of the entrusted production enterprises, and supervise the production activities of the entrusted production enterprises; 2、 A person in charge of quality and safety shall be set up and assume corresponding responsibilities; 3、 Samples shall be reserved and meet relevant requirements; 4、 Be responsible for the release of products on the market; 5、 A record management system shall be established and implemented to supervise the entrusted production enterprises to keep relevant records of the implementation of production quality management specifications.
Company announcement:
Fourth Ring medicine: its flag space has recently reached exclusive agreement with VIOL Korea on gold micro needle products, and has obtained the exclusive agency right in Chinese mainland, Hongkong and Macao.
Syoung Group Co.Ltd(300740) : release the performance forecast for 2021. The net profit attributable to the shareholders of the listed company is expected to increase by about 64% ~ 89% over the same period of the previous year, and the expected profit is RMB 230 million ~ 265 million.
Investment advice
(1) cosmetics industry: Syoung Group Co.Ltd(300740) 2021 annual performance forecast was released, the construction of self owned + agent brand matrix was gradually completed, and the profitability was significantly improved. Continue to pay attention to the performance forecast of Companies in the cosmetics industry. Focus on: [ Yunnan Botanee Bio-Technology Group Co.Ltd(300957) ] subdivide the leaders in the field of sensitive muscle skin care; [ Proya Cosmetics Co.Ltd(603605) ] diversified high-quality brands; [ Shanghai Jahwa United Co.Ltd(600315) ] multi category development and continuous innovation to create new items; [ Guangdong Marubi Biotechnology Co.Ltd(603983) ] mainly focuses on medium and high-end, with rich marketing and distribution channels; [ Syoung Group Co.Ltd(300740) ] strong operation capacity and gradual improvement of category structure;
(2) medical beauty industry: the demand side of the medical beauty industry continues to expand, the supply side products are more diversified, and the policy side strengthens the supervision of medical beauty institutions and medical beauty products. We are optimistic about upstream medical and American enterprises with class III medical device certificate and perfect product matrix layout and downstream medical institutions with long-term standardized operation. Attention: [ Bloomage Biotechnology Corporation Limited(688363) ] local hyaluronic acid raw material leader; [ Imeik Technology Development Co.Ltd(300896) ] Tongyan needle is heavily listed and differentiated to meet higher needs; [ Huadong Medicine Co.Ltd(000963) ] overall layout of medical and American business; [ Shanghai Haohai Biological Technology Co.Ltd(688366) ] integration of R & D, production and sales; [tetracyclic medicine] botulinum toxin + double antibody go hand in hand; Pay attention to Lancy Co.Ltd(002612) and so on.
Risk tips
Risk of intensified industry competition; Uncertainty of industry regulatory policies; Macroeconomic fluctuations, etc.
